tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kerry Holford, 12 are a HOLD (63.16%), 7 are a BUY (36.84%).
Analyst Kerry Holford, currently employed at BERENBERG, carries an average stock price target met ratio of 76.19% that have a potential upside of 14.29% achieved within 197 days.
Kerry Holford’s has documented 33 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 17-Sep-2025.
Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 10/11/2021. The price target of $270 was fulfilled within 66 days with a profit of $44.3 (19.63%) receiving and performance score of 2.97.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$41
$0.33 (0.81%)
9 months 23 days ago
(02-Dec-2024)
1/1 (100%)
$6.69 (19.50%)
179
Hold
$53
10 months 13 days ago
(12-Nov-2024)
2/4 (50%)
$15.58 (41.64%)
379
Buy
1 years 1 months 24 days ago
(01-Aug-2024)
1/13 (7.69%)
$-10.5 (-32.65%)
64
Buy
$45
$4.33 (10.65%)
$47
1 years 2 months 9 days ago
(16-Jul-2024)
1/3 (33.33%)
$6.9 (18.11%)
2259
Buy
$19.52
1 years 7 months 12 days ago
(13-Feb-2024)
0/3 (0%)
$-13.88 (-41.56%)
Which stock is Kerry Holford is most bullish on?
What Year was the first public recommendation made by Kerry Holford?
